Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Roussakis, AA"'
Autor:
Wilkins, M, McKie, M, Law, M, Roussakis, AA, Harbaum, L, Church, C, Coghlan, JG, Condliffe, R, Howard, L, Kiely, D, Lordan, J, Rothman, A, Suntharalingam, J, Toshner, M, Wort, J, Villar, SS
Pulmonary arterial hypertension is an unmet clinical need. Imatinib, a tyrosine kinase inhibitor, 200 to 400 mg daily reduces pulmonary artery pressure and increases functional capacity in this patient group, but is generally poorly tolerated at the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::93bd2fa863fc00c1d3ab95e284f64c84
http://hdl.handle.net/10044/1/91997
http://hdl.handle.net/10044/1/91997
Autor:
Li, W, Lao-Kaim, N, Roussakis, AA, Martin Bastida, A, Valle Guzman, N, Paul, G, Loane, C, Widner, H, Politis, M, Foltynie, T, Barker, R, Piccini, P
Background 18F-dopa PET measuring aromatic l-amino acid decarboxylase activity is regarded as the gold standard for evaluating dopaminergic function in Parkinson's disease. Radioligands for dopamine transporters are also used in clinical trials and f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::d293f13a12814ef2cf9a6f15f91cd2fe
http://hdl.handle.net/10044/1/50554
http://hdl.handle.net/10044/1/50554
Autor:
Roussakis, AA, Lao-Kaim, Martin-Bastida, A, Valle-Guzman, N, Kefalopoulou, Z, Paul, G, Widner, H, Politis, M, Foltynie, T, Barker, RA, Piccini
Publikováno v:
2nd Congress of the European Academy of Neurology
Background and aims Serotonergic terminals play an important role in levodopa-induced dyskinesias (LIDs) in patients with Parkinson’s disease (PD). An increased SERT-over-DAT terminal ratio in the putamen has been proposed to be a risk factor for t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::e9fd942984fdae4aab338492af9949d0
http://hdl.handle.net/10044/1/30906
http://hdl.handle.net/10044/1/30906
Publikováno v:
American Academy of Neurology 67th Annual Meeting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::dd9d1133bb5df37469585ef51044d456
http://hdl.handle.net/10044/1/31578
http://hdl.handle.net/10044/1/31578
Autor:
Roussakis AA; Brain Sciences, Imperial College London, Hammersmith Hospital, London W12 0NN, UK., Gennaro M; Brain Sciences, Imperial College London, Hammersmith Hospital, London W12 0NN, UK., Gordon MF; Teva Pharmaceuticals, West Chester, PA 19380, USA., Reilmann R; George-Huntington-Institute, Münster 48149, Germany., Borowsky B; Teva Pharmaceuticals, West Chester, PA 19380, USA., Rynkowski G; Teva Pharmaceuticals, West Chester, PA 19380, USA., Lao-Kaim NP; Brain Sciences, Imperial College London, Hammersmith Hospital, London W12 0NN, UK., Papoutsou Z; Brain Sciences, Imperial College London, Hammersmith Hospital, London W12 0NN, UK., Savola JM; Teva Pharmaceuticals International GmbH, 4051 Basel, Switzerland., Hayden MR; Centre for Molecular Medicine and Therapeutics, BC Children's Hospital and Research Institute, University of British Columbia, Vancouver V5Z 4H4, Canada., Owen DR; Brain Sciences, Imperial College London, Hammersmith Hospital, London W12 0NN, UK., Kalk N; Brain Sciences, Imperial College London, Hammersmith Hospital, London W12 0NN, UK., Lingford-Hughes A; Brain Sciences, Imperial College London, Hammersmith Hospital, London W12 0NN, UK., Gunn RN; Brain Sciences, Imperial College London, Hammersmith Hospital, London W12 0NN, UK.; Invicro, Hammersmith Hospital,, London W12 0NN, UK., Searle G; Invicro, Hammersmith Hospital,, London W12 0NN, UK., Tabrizi SJ; Huntington's Disease Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK., Piccini P; Brain Sciences, Imperial College London, Hammersmith Hospital, London W12 0NN, UK.
Publikováno v:
Brain communications [Brain Commun] 2023 Apr 03; Vol. 5 (2), pp. fcad084. Date of Electronic Publication: 2023 Apr 03 (Print Publication: 2023).
Autor:
Mohamed MA; Department of Brain Sciences, Imperial College London, Hammersmith Hospital, London, UK., Zeng Z; Department of Brain Sciences, Imperial College London, Hammersmith Hospital, London, UK.; Xiangya Hospital of Central South University, Changsha, Hunan, P.R. China., Gennaro M; Department of Brain Sciences, Imperial College London, Hammersmith Hospital, London, UK., Lao-Kaim NP; Department of Brain Sciences, Imperial College London, Hammersmith Hospital, London, UK., Myers JFM; Department of Brain Sciences, Imperial College London, Hammersmith Hospital, London, UK., Calsolaro V; Department of Brain Sciences, Imperial College London, Hammersmith Hospital, London, UK., Femminella GD; Department of Brain Sciences, Imperial College London, Hammersmith Hospital, London, UK.; Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy., Tyacke RJ; Department of Brain Sciences, Imperial College London, Hammersmith Hospital, London, UK., Martin-Bastida A; Department of Brain Sciences, Imperial College London, Hammersmith Hospital, London, UK.; Department of Neurology and Neurosciences, Clinica Universidad de Navarra, Pamplona-Madrid, Spain., Gunn RN; Department of Brain Sciences, Imperial College London, Hammersmith Hospital, London, UK., Nutt DJ; Department of Brain Sciences, Imperial College London, Hammersmith Hospital, London, UK., Edison P; Department of Brain Sciences, Imperial College London, Hammersmith Hospital, London, UK., Piccini P; Department of Brain Sciences, Imperial College London, Hammersmith Hospital, London, UK., Roussakis AA; Department of Brain Sciences, Imperial College London, Hammersmith Hospital, London, UK.
Publikováno v:
Brain communications [Brain Commun] 2022 Aug 18; Vol. 4 (5), pp. fcac199. Date of Electronic Publication: 2022 Aug 18 (Print Publication: 2022).
Autor:
Wilkins MR; National Heart and Lung Institute, Faculty of Medicine, Imperial College London, Hammersmith Hospital, London, UK., Mckie MA; MRC Biostatistics Unit, School of Clinical Medicine, Cambridge Institute of Public Health, Cambridge, UK., Law M; MRC Biostatistics Unit, School of Clinical Medicine, Cambridge Institute of Public Health, Cambridge, UK., Roussakis AA; National Heart and Lung Institute, Faculty of Medicine, Imperial College London, Hammersmith Hospital, London, UK., Harbaum L; National Heart and Lung Institute, Faculty of Medicine, Imperial College London, Hammersmith Hospital, London, UK., Church C; Golden Jubilee National Hospital, University of Glasgow, Scotland, UK.; Royal Free Hospital, Royal Free London NHS Foundation Trust, London, UK., Coghlan JG; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK., Condliffe R; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.; National Pulmonary Hypertension Service, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK., Howard LS; Newcastle Freeman Hospital, Freeman Road, High Heaton, Newcastle Upon Tyne, UK., Kiely DG; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.; National Pulmonary Hypertension Service, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK., Lordan J; Royal United Hospital, Royal United Hospitals Bath NHS Foundation Trust, Bath, UK., Rothman A; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.; National Pulmonary Hypertension Service, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK., Suntharalingam J; Heart Lung Research Institute, University of Cambridge, Cambridge, UK., Toshner M; Department of Medicine, University of Cambridge, Cambridge, UK.; Royal Brompton Hospital, Guy's and St Thomas's Trust, London, UK., Wort SJ; Golden Jubilee National Hospital, NHS Greater Glasgow and Clyde, Clydebank, UK., Villar SS; MRC Biostatistics Unit, School of Clinical Medicine, Cambridge Institute of Public Health, Cambridge, UK.
Publikováno v:
Pulmonary circulation [Pulm Circ] 2021 Oct 17; Vol. 11 (4), pp. 20458940211052823. Date of Electronic Publication: 2021 Oct 17 (Print Publication: 2021).
Autor:
Parkin BL; Department of Psychology, School of Social Science, University of Westminster, 115 New Cavendish Street, London, W1W 6UW, UK., Daws RE; The Cognitive, Computational and Clinical Neuroscience Laboratory, Department of Medicine, Imperial College London, London W120NN, UK., Das-Neves I; The Cognitive, Computational and Clinical Neuroscience Laboratory, Department of Medicine, Imperial College London, London W120NN, UK., Violante IR; The Cognitive, Computational and Clinical Neuroscience Laboratory, Department of Medicine, Imperial College London, London W120NN, UK.; School of Psychology, Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7XH, UK., Soreq E; The Cognitive, Computational and Clinical Neuroscience Laboratory, Department of Medicine, Imperial College London, London W120NN, UK., Faisal AA; Brain and Behaviour Laboratory, Department of Bioengineering, Imperial College London, London W12 0NN, UK.; Brain and Behaviour Laboratory, Department of Computing, Imperial College London, London W12 0NN, UK.; Behaviour Analytics Lab, Data Science Institute, Imperial College London, London W12 0NN, UK.; MRC London Institute of Medical Sciences, London W12 0NN, UK., Sandrone S; The Cognitive, Computational and Clinical Neuroscience Laboratory, Department of Medicine, Imperial College London, London W120NN, UK., Lao-Kaim NP; Neurology Imaging Unit, Division of Neurology, Imperial College London, London W12 0NN, UK., Martin-Bastida A; Neurology Imaging Unit, Division of Neurology, Imperial College London, London W12 0NN, UK.; Department of Neurology and Neurosciences, Clinica Universidad de Navarra, Pamplona-Madrid 28027, Spain., Roussakis AA; Neurology Imaging Unit, Division of Neurology, Imperial College London, London W12 0NN, UK., Piccini P; Neurology Imaging Unit, Division of Neurology, Imperial College London, London W12 0NN, UK., Hampshire A; The Cognitive, Computational and Clinical Neuroscience Laboratory, Department of Medicine, Imperial College London, London W120NN, UK.; UK DRI Care Research & Technology Centre, Imperial College London, London W12 0NN, UK.
Publikováno v:
Brain communications [Brain Commun] 2021 Aug 28; Vol. 3 (3), pp. fcab175. Date of Electronic Publication: 2021 Aug 28 (Print Publication: 2021).
Autor:
Hannaway N; Neurology Imaging Unit, Division of Neurology, Department of Brain Sciences, Imperial College London, London, W12 0NN, United Kingdom. Electronic address: n.hannaway@ucl.ac.uk., Lao-Kaim NP; Neurology Imaging Unit, Division of Neurology, Department of Brain Sciences, Imperial College London, London, W12 0NN, United Kingdom. Electronic address: n.kaim@imperial.ac.uk., Martín-Bastida A; Neurology Imaging Unit, Division of Neurology, Department of Brain Sciences, Imperial College London, London, W12 0NN, United Kingdom; Neurology Department, Clinica Universidad de Navarra, Pamplona, Navarra, 31008, Spain. Electronic address: amartin@unav.es., Roussakis AA; Neurology Imaging Unit, Division of Neurology, Department of Brain Sciences, Imperial College London, London, W12 0NN, United Kingdom. Electronic address: a.roussakis@imperial.ac.uk., Howard J; Invicro LLC, London, W12 0NN, United Kingdom. Electronic address: jonathan.howard@invicro.co.uk., Wall MB; Invicro LLC, London, W12 0NN, United Kingdom. Electronic address: matt.wall@invicro.co.uk., Loane C; Maurice Wohl Clinical Neuroscience Institute, King's College London, London, SE5 9RT, United Kingdom. Electronic address: clare.loane@kcl.ac.uk., Barker RA; John Van Geest Centre for Brain Repair, University of Cambridge, Cambridge CB2 0PY, United Kingdom and WT-MRC Cambridge Stem Cell, Cambridge, United Kingdom. Electronic address: rab46@cam.ac.uk., Piccini P; Neurology Imaging Unit, Division of Neurology, Department of Brain Sciences, Imperial College London, London, W12 0NN, United Kingdom. Electronic address: paola.piccini@imperial.ac.uk.
Publikováno v:
Parkinsonism & related disorders [Parkinsonism Relat Disord] 2021 Jun; Vol. 87, pp. 61-69. Date of Electronic Publication: 2021 May 04.
Autor:
Roussakis AA; Division of Neurology, Neurology Imaging Unit, Hammersmith Hospital, Imperial College London, Du Cane Road, London, W12 0NN, UK., Zeng Z; Division of Neurology, Neurology Imaging Unit, Hammersmith Hospital, Imperial College London, Du Cane Road, London, W12 0NN, UK.; Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China., Lao-Kaim NP; Division of Neurology, Neurology Imaging Unit, Hammersmith Hospital, Imperial College London, Du Cane Road, London, W12 0NN, UK., Martin-Bastida A; Division of Neurology, Neurology Imaging Unit, Hammersmith Hospital, Imperial College London, Du Cane Road, London, W12 0NN, UK.; Department of Neurology and Neurosciences, Clinica Universidad de Navarra, Pamplona, Madrid, Spain., Piccini P; Division of Neurology, Neurology Imaging Unit, Hammersmith Hospital, Imperial College London, Du Cane Road, London, W12 0NN, UK. paola.piccini@imperial.ac.uk.
Publikováno v:
Journal of neurology [J Neurol] 2021 Feb; Vol. 268 (2), pp. 582-589. Date of Electronic Publication: 2020 Sep 02.